The Biological Ground Truth for AI-Driven Drug Discovery
We are building the world's first data engine to generate systemic, in vivo data at an industrial scale, making AI-driven drug discovery finally predictive.
Pharma's $200 billion paradoxs
Why AI Predictions Fail in Humans
The AI revolution was meant to fix pharma's 90% failure rate. Instead, it's hitting the same wall: a fundamental lack of predictive, systemic data. This is the 'Systemic Data Gap'.
Siloed Biology
Cellular assays, pre-clinical models, and human clinical data exist in separate worlds.
Scalability Desert
Current high-throughput methods (in vitro) are scalable but simplistic, with less than 40% translatability.
Reductionist Models
All today's available methods miss the multi-organ, systemic effects that cause drugs to fail in humans.
Bridging these translational gaps is the critical barrier to predictive drug discovery.
Our Solution
Industrializing In Vivo Biology
We are the first company to industrialize in vivo data generation. Our platform connects siloed knowledge, revealing the complete picture of systemic biology.
We connect biology's dim stars to reveal new constellations of insight.
The Industrialized In Vivo Platform
A hybrid of proprietary hardware and off-the-shelf robotics, enabling standardized experiments at a scale and consistency competitors cannot match.
The Zebrafish Model at Scale
We unlock the power of a proven biological model (84% human gene homology) that was previously limited by technology, not biology. Systemic, scalable, and ethically sound.
ZebrAI™: Our Intelligence Engine
Our AI engine that enriches data and aligns biological profiles with human clinical data, reaching over 80% translatability.
Traction & Validation
Validated by the Industry
Our groundbreaking approach is gaining significant traction with key players across the ecosystem.
Trusted by Leading Partners & Programs
And Strong Commercial Interest
0Letters of Intent
from AI-Biotech & Pharma leaders
The Architects
Meet The Founding Team
A multidisciplinary team with deep expertise across biology, engineering, and artificial intelligence.
Valerio Laghi
Chief Executive Officer
PhD in Immunology with a decade of experience in high-throughput zebrafish screening and automation.
Lorenzo Zolfanelli
Chief Scientific Officer
PhD in Biophysics and former lead engineer for industrial-scale HTS screening platforms.
Guillaume De Luca
Chief Data Officer
PhD in Engineering with deep expertise in creating data-driven and AI-based industrial solutions.
Backed by World-Class Advisors
Our scientific and business advisors include world-class experts in biology automation, molecular libraries, and zebrafish neuroimmunology from universities and institutions like Institut Pasteur and TEFOR, alongside seasoned leaders in pharma market access strategy and deeptech startup operations.
Unlock Ground Truth
Generate the Data That Matters
Our platform generates novel biomarkers, uncovers mechanisms of action, and provides the systemic in vivo data to power the next generation of therapeutics. Partner with us to close the loop between AI design and biological reality.